CoChat

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria

Open access
Foss, Stian, Sakya, Siri A., Aguinagalde, Leire, Lustig, Marta, Shaughnessy, Jutamas, Cruz, Ana Rita, Scheepmaker, Lisette, Mathiesen, Line, Ruso-Julve, Fulgencio, Anthi, Aina Karen, Gjølberg, Torleif Tollefsrud, Mester, Simone, Bern, Malin, Evers, Mitchell, Bratlie, Diane B., Michaelsen, Terje E., Schlothauer, Tilman, Sok, Devin, Bhattacharya, Jayanta, Leusen, Jeanette, Valerius, Thomas, Ram, Sanjay, Rooijakkers, Suzan H. M., Sandlie, Inger, Andersen, Jan Terje · 2024 · Nature Communications
Cited by 82

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Monoclonal IgG antibodies constitute the fastest growing class of therapeutics. Thus, there is an intense interest to design more potent antibody formats, where long plasma half-life is a commercially competitive differentiator affecting dosing, frequency of administration and thereby potentially patient compliance. Here, we report on an Fc-engineered variant with three amino acid substitutions Q311R/M428E/N434W (REW), that enhances plasma half-life and mucosal distribution, as well as allows for needle-free delivery across respiratory epithelial barriers in human FcRn transgenic mice. In addition, the Fc-engineered variant improves on-target complement-mediated killing of cancer cells as well as both gram-positive and gram-negative bacteria. Hence, this versatile Fc technology should be broadly applicable in antibody design aiming for long-acting prophylactic or therapeutic interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-024-46321-9

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 82

Metadata

Authors
Foss, S., Sakya, S. A., Aguinagalde, L., Lustig, M., Shaughnessy, J., Cruz, A. R., Scheepmaker, L., Mathiesen, L., Ruso-Julve, F., Anthi, A. K., Gjølberg, T. T., Mester, S., Bern, M., Evers, M., Bratlie, D. B., Michaelsen, T. E., Schlothauer, T., Sok, D., Bhattacharya, J., Leusen, J., Valerius, T., Ram, S., Rooijakkers, S. H. M., Sandlie, I., & Andersen, J. T.
Venue
Nature Communications
Published
2024-03-07
Volume
15
Issue
1
Pages
2007-2007
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4392553115
Cited by
82
References
12
FWCI
18.86
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria. https://app.cochat.ai/papers/10.1038/s41467-024-46321-9
The paper
Foss, S., Sakya, S. A., Aguinagalde, L., Lustig, M., Shaughnessy, J., Cruz, A. R., Scheepmaker, L., Mathiesen, L., Ruso-Julve, F., Anthi, A. K., Gjølberg, T. T., Mester, S., Bern, M., Evers, M., Bratlie, D. B., Michaelsen, T. E., Schlothauer, T., Sok, D., Bhattacharya, J., . . . Andersen, J. T. (2024). Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria. Nature Communications. https://doi.org/10.1038/s41467-024-46321-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.